Lluvido, Almera T.
HRN: 23-12-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2023
CEFAZOLIN 1GM (VIAL)
05/30/2023
05/30/2023
IV
2g
En Route To OR
Stat Primary CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes